A Phase 1 Pharmacokinetic And Pharmacodynamic Study Of PF-03732010 In Patients With Advanced Solid Tumors.

Trial Profile

A Phase 1 Pharmacokinetic And Pharmacodynamic Study Of PF-03732010 In Patients With Advanced Solid Tumors.

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Feb 2012

At a glance

  • Drugs PF 3732010 (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions; Biomarker
  • Most Recent Events

    • 04 Jan 2012 Actual patient number changed from 44 to 43 as reported by ClinicalTrials.gov.
    • 12 Apr 2011 Actual patient numbers reported as 42 by ClinicalTrials.gov
    • 12 Apr 2011 Status changed from active, no longer recruiting to completed, as reported by the ClinicalTrials.gov record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top